Evonik Industries AG, Teva Pharmaceutical Industries Ltd., Lonza Group AG, Catalent Inc., and Patheon Pharma Services Lead ...

DUBLIN--(BUSINESS WIRE)--The "U.S. Oral Solid Dosage Contract Manufacturing Market Size, Share & Trends Analysis Report By Product Type (Tablets, Capsules), By Mechanism (Controlled-, ...

The pharmaceutical market for the solid oral dosage forms like tablets and capsules remain well built, dominated and continuously evolving through several innovative tools for pharmaceutical process ...

(MENAFN- EIN Presswire) EINPresswire/ -- The global Oral Solid Dosage (OSD) Pharmaceutical Formulation Market is set to surge from USD 779.44 Billion in 2024 to USD 1,349.27 Billion by 2032, at a 7.1% ...

The MENA pharmaceutical contract manufacturing market is poised for growth due to the rise in outsourcing trends, fueled by increasing healthcare demands, government localization initiatives, and ...

The "Oral Solid Dosage Manufacturing Market Industry Trends and Global Forecasts to 2035, by Type of Finished Dosage Form, Type of Packaging, Scale of Operation, Company Size, Therapeutic Area, and ...

When designing mechanical systems for nonsterile solid dosage drugs, there is more to consider than just the design/selection of the actual HVAC equipment. There are many factors and components of the ...

The processing of complex oral solid dosage, from formulation design to scale-up and manufacturing is fraught with several challenges; as a result, drug developers are increasingly relying on service ...

ATLANTA, Feb. 15, 2024 /PRNewswire/ -- Mikart, LLC, a leading Contract Development and Manufacturing Organization (CDMO), announces the addition of cutting-edge, Fette ® double-sided tablet presses to ...

Forma Life Sciences Launches U.S. Based Contract Development and Manufacturing Organization (CDMO) for Oral Solid Dosage Development and Commercial Manufacturing in Irvine, California Forma Life ...

Key market opportunities in the CDMO for formulations sector include increasing demand for custom peptide synthesis, ...

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) announced today a multi-year collaboration with GSK on the development of a next-generation equipment design, building upon Pfizer’s existing portable ...